Logo image of BNBX

BNB PLUS CORP (BNBX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BNBX - US03815U6073 - Common Stock

2.64 USD
+0.04 (+1.54%)
Last: 12/1/2025, 8:00:02 PM
Fundamental Rating

3

Taking everything into account, BNBX scores 3 out of 10 in our fundamental rating. BNBX was compared to 58 industry peers in the Life Sciences Tools & Services industry. While BNBX seems to be doing ok healthwise, there are quite some concerns on its profitability. BNBX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

BNBX had negative earnings in the past year.
In the past year BNBX has reported a negative cash flow from operations.
BNBX had negative earnings in each of the past 5 years.
In the past 5 years BNBX always reported negative operating cash flow.
BNBX Yearly Net Income VS EBIT VS OCF VS FCFBNBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

The Return On Assets of BNBX (-679.56%) is worse than 96.55% of its industry peers.
BNBX has a worse Return On Equity (-929.59%) than 91.38% of its industry peers.
Industry RankSector Rank
ROA -679.56%
ROE -929.59%
ROIC N/A
ROA(3y)-55.66%
ROA(5y)-76.19%
ROE(3y)-114.94%
ROE(5y)-140.25%
ROIC(3y)N/A
ROIC(5y)N/A
BNBX Yearly ROA, ROE, ROICBNBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 39.57%, BNBX is in line with its industry, outperforming 41.38% of the companies in the same industry.
BNBX's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for BNBX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.42%
GM growth 5Y-18.75%
BNBX Yearly Profit, Operating, Gross MarginsBNBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

6

2. Health

2.1 Basic Checks

BNBX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BNBX has been increased compared to 1 year ago.
Compared to 5 years ago, BNBX has more shares outstanding
There is no outstanding debt for BNBX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BNBX Yearly Shares OutstandingBNBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2K 4K 6K 8K 10K
BNBX Yearly Total Debt VS Total AssetsBNBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -53.83, we must say that BNBX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BNBX (-53.83) is worse than 94.83% of its industry peers.
There is no outstanding debt for BNBX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -53.83
ROIC/WACCN/A
WACC10.15%
BNBX Yearly LT Debt VS Equity VS FCFBNBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

2.3 Liquidity

A Current Ratio of 2.76 indicates that BNBX has no problem at all paying its short term obligations.
BNBX's Current ratio of 2.76 is in line compared to the rest of the industry. BNBX outperforms 51.72% of its industry peers.
BNBX has a Quick Ratio of 2.60. This indicates that BNBX is financially healthy and has no problem in meeting its short term obligations.
BNBX's Quick ratio of 2.60 is in line compared to the rest of the industry. BNBX outperforms 56.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.76
Quick Ratio 2.6
BNBX Yearly Current Assets VS Current LiabilitesBNBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 89.59% over the past year.
The Revenue has decreased by -2.96% in the past year.
The Revenue has been decreasing by -8.63% on average over the past years.
EPS 1Y (TTM)89.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.65%
Revenue 1Y (TTM)-2.96%
Revenue growth 3Y-27.56%
Revenue growth 5Y-8.63%
Sales Q2Q%-61.83%

3.2 Future

The Earnings Per Share is expected to grow by 40.85% on average over the next years. This is a very strong growth
BNBX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.04% yearly.
EPS Next Y92.97%
EPS Next 2Y40.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50.26%
Revenue Next 2Y45.04%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BNBX Yearly Revenue VS EstimatesBNBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
BNBX Yearly EPS VS EstimatesBNBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -100K -200K -300K

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNBX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BNBX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BNBX Price Earnings VS Forward Price EarningsBNBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BNBX Per share dataBNBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -200 -400 -600 -800

4.3 Compensation for Growth

A more expensive valuation may be justified as BNBX's earnings are expected to grow with 40.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BNBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BNB PLUS CORP

NASDAQ:BNBX (12/1/2025, 8:00:02 PM)

2.64

+0.04 (+1.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)12-11 2025-12-11/amc
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners0.4%
Ins Owner Change65.99%
Market Cap11.48M
Revenue(TTM)3.30M
Net Income(TTM)-67.51M
Analysts43.33
Price TargetN/A
Short Float %20.61%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-195.26%
Min EPS beat(2)-401.63%
Max EPS beat(2)11.11%
EPS beat(4)2
Avg EPS beat(4)-112.93%
Min EPS beat(4)-401.63%
Max EPS beat(4)11.11%
EPS beat(8)5
Avg EPS beat(8)-19.83%
EPS beat(12)8
Avg EPS beat(12)5.22%
EPS beat(16)10
Avg EPS beat(16)-1.91%
Revenue beat(2)0
Avg Revenue beat(2)-47.64%
Min Revenue beat(2)-76.62%
Max Revenue beat(2)-18.66%
Revenue beat(4)1
Avg Revenue beat(4)-23.38%
Min Revenue beat(4)-76.62%
Max Revenue beat(4)13.1%
Revenue beat(8)2
Avg Revenue beat(8)-20.61%
Revenue beat(12)5
Avg Revenue beat(12)-11.63%
Revenue beat(16)9
Avg Revenue beat(16)-3.58%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.48
P/FCF N/A
P/OCF N/A
P/B 1.58
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-924.25
EYN/A
EPS(NY)-84.15
Fwd EYN/A
FCF(TTM)-3.05
FCFYN/A
OCF(TTM)-2.89
OCFYN/A
SpS0.76
BVpS1.67
TBVpS1.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -679.56%
ROE -929.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.57%
FCFM N/A
ROA(3y)-55.66%
ROA(5y)-76.19%
ROE(3y)-114.94%
ROE(5y)-140.25%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.42%
GM growth 5Y-18.75%
F-Score4
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 205.74%
Cap/Sales 20.75%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.76
Quick Ratio 2.6
Altman-Z -53.83
F-Score4
WACC10.15%
ROIC/WACCN/A
Cap/Depr(3y)60.08%
Cap/Depr(5y)170.88%
Cap/Sales(3y)7.71%
Cap/Sales(5y)21.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)89.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-109.65%
EPS Next Y92.97%
EPS Next 2Y40.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.96%
Revenue growth 3Y-27.56%
Revenue growth 5Y-8.63%
Sales Q2Q%-61.83%
Revenue Next Year50.26%
Revenue Next 2Y45.04%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-85.04%
OCF growth 3YN/A
OCF growth 5YN/A

BNB PLUS CORP / BNBX FAQ

Can you provide the ChartMill fundamental rating for BNB PLUS CORP?

ChartMill assigns a fundamental rating of 3 / 10 to BNBX.


What is the valuation status of BNB PLUS CORP (BNBX) stock?

ChartMill assigns a valuation rating of 1 / 10 to BNB PLUS CORP (BNBX). This can be considered as Overvalued.


How profitable is BNB PLUS CORP (BNBX) stock?

BNB PLUS CORP (BNBX) has a profitability rating of 0 / 10.